Reducing pressure on health services by task-shifting

One major factor that allowed treatment scale-up to today’s levels was the fact that the price of ARVs dropped dramatically over the past decade, from more than US$10,000 in 2000 to roughly $150 today.  This price decline has made lifesaving drugs accessible to millions of people in developing countries. The newer generation of ARVs has fewer side-effects, which has a positive effect on people’s ability to adhere to their treatment.